Biosimilar Market Size, Business Opportunity and Future Demand by 2028 | IMARC Group

 The latest report published by IMARC Group, titled “Biosimilar Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the market share. The report also includes competitor and regional analysis, and contemporary advancements in the market.

How Big is the Biosimilar Market?

The global biosimilar market size reached US$ 16.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 77.1 Billion by 2028, exhibiting a growth rate (CAGR) of 25.9% during 2023-2028.

Biosimilars are biological products that are highly like already approved and commercially available biological medicines, known as originators or reference products. These are not generic versions, as biological medicines are complex molecules produced using living cells. Biosimilars are rigorously tested to ensure they match the safety, efficacy, and quality of the original biologic drug. They are used in the treatment of a variety of medical conditions, including autoimmune diseases, cancer, and diabetes. Regulatory agencies like the U.S. FDA and the European Medicines Agency have specific pathways for the approval of biosimilars to ensure their safety and effectiveness.

Request a Free PDF Sample for More Detailed Market Insights:  https://www.imarcgroup.com/biosimilar-market/requestsample

Biosimilar Market Trends:

One of the primary advantages of biosimilars is their cost-effectiveness compared to original biologic drugs which represents one of the key factors driving the market growth across the globe. They provide a more affordable option for healthcare systems and patients, which is increasing their demand. The expiration of patents for several blockbuster biologic drugs has opened the door for biosimilars to enter the market which is driving competition and lowering prices. Advances in biotechnology and pharmaceutical sciences are making it easier to produce biosimilars that meet the stringent safety and efficacy requirements comparable to their reference biologics. Developing countries offer a large patient base that is becoming increasingly accessible due to improving healthcare infrastructure, which is driving the demand for cost-effective biosimilars. Healthcare providers and payers are pushing for the adoption of biosimilars as a cost-saving measure, which is further propelling the market. The increasing public awareness about the effectiveness and safety of biosimilars is gradually reducing skepticism, which is increasing adoption rates, thus facilitating the growth of the market across the globe.

Competitive Landscape With Key Players:

The competitive landscape of the biosimilar market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Novartis
• Pfizer
• Teva
• Celltrion
• Merck & Co
• Samsung Bioepis
• Eli Lilly
• Biocon
• Reddy’s Laboratories
• Amgen
• Boehringer Ingelheim

 Key Market Segmentation:

The report has segmented the global biosimilar market based on molecule, indication and manufacturing type.

Molecule insights: 

• Infliximab
• Insulin Glargine
• Epoetin Alfa
• Etanercept
• Filgrastim
• Somatropin
• Rituximab
• Follitropin Alfa

Indication Insights:

• Auto-Immune Diseases
• Blood Disorder
• Diabetes
• Oncology
• Growth Deficiency
• Female Infertility

Manufacturing Insights:

• In-house Manufacturing
• Contract Manufacturing

Regional Insights:

• United States
• Germany
• France
• Italy
• Spain
• United Kingdom
• Japan
• India
• South Korea
• Others

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=497&flag=C

Key Highlights of The Report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/